Loading company…
RainPath develops AI technology for digital biopsy analysis and virtual tissue staining.
Founded in 2025 and based in Paris, France, RainPath develops AI-powered virtual staining technology for biopsy analysis. Its software is designed to help pathologists and histopathology laboratories analyze tissue without traditional wet staining. In July 2025, it raised EUR 2.5 million from Teampact Ventures to develop its technology and products.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in